Skip to main content
. Author manuscript; available in PMC: 2014 Feb 21.
Published in final edited form as: Immunity. 2013 Feb 21;38(2):10.1016/j.immuni.2012.10.022. doi: 10.1016/j.immuni.2012.10.022

Figure 2. see also Figure S2: CD8+ T Cell stimulatory capacity of APCs from LCMV infected mice.

Figure 2

(A) Total proliferating CFSE-labeled OT-I T cells following culture with CD11c+ DC or CD11c− CD11b+ myeloid cells 24hr p.i. Proliferation was measured by flow cytometry after 3 days of culture with different amounts of SIINFEKL peptide.

(B) Total DC and myeloid cells from day 7 p.i. or day 14 p.i. (C) were bead purified and cultured with purified OVA-specific OT1 T cells as in previous figure.

Data are representative of 3 (A) or 2 (B-C) experiments.